CMS: Inflation Reduction Act (IRA) Initial Program Guidance; Comment Request

Notice from the Centers for Medicare& Medicaid Services (CMS) seeking comments on the initial CMS guidance for the Medicare Part B and Part D Prescription Drug Inflation Rebate Program as part of the Inflation Reduction Act. Additional Inflation Reduction Act-related guidance will be shared on the dedicatedInflation Reduction Act section of the CMS website. Comments are due by March 11, 2023.
Source: Federal Register updates via the Rural Assistance Center - Category: Rural Health Source Type: news